Healthcare Strategic Plan Initiative Grand Canyon University

Healthcare Strategic Plan Initiativegrand Canyon University5152022he

Healthcare Strategic Plan Initiative Grand Canyon University 5/15/2022 Healthcare Strategic Plan Initiative Adverse Drug Events in elderly Older people have repeatedly reported cases of adverse drug events. These problems have been presented in offices, extended care facilities, and hospitals. They are caused by diuretics, anti-inflammatory drugs, antithrombotic medications, and antidiabetic medications (Pretorius et al., 2013). These events can be prevented through discontinuation of medications, prescription of new medications sparingly, reduction in the number of prescribers, and reconciliation of medications frequently. The plan below describes an initiative to reduce adverse drug events in the elderly.

Goal: Reduce the number of hospital admissions as a result of adverse drug events within the next 12 months.

Below is a breakdown of the steps required to ensure our goal is met:

Initiative Steps and Implementation Details

1. Clinical Decision Support Systems (CDSS)

Actions: Confirm the medication history of the patient, identify medications for deprescribing, decide with clients, synthesize recommendations (Earl et al., 2020).

Budget: $400

Time Frame: Six months

2. Interventions: Education Improvement

Actions: Describe the risks associated with certain medications; provide educational brochures to clients.

Duration: Implement over several months, with ongoing reinforcement as needed.

3. Medication Reviews by Pharmacists

Actions: Incorporate clinical pharmacists into primary care settings to conduct comprehensive medication reviews.

Duration: Six months

4. Medication Reviews by Clinicians

Actions: Include clinicians in primary care to perform medication reviews to identify and deprescribe unnecessary medications.

Duration: Six months

Organizational Culture and Challenges

The organization is composed of staff and administration that are generally cautious about adopting new interventions. However, they support the use of evidence-based practices for improving patient care. Potential challenges include financial constraints, obtaining permission to implement the initiatives, and ensuring full participation of all involved professionals. Addressing these issues requires strategic leadership to foster a culture that values innovation and quality improvement, as well as securing necessary resources and authority for implementation.

Conclusion

This initiative aims to significantly reduce adverse drug events among the elderly by leveraging technology, education, and interprofessional collaboration. Successful implementation will depend on overcoming organizational resistance and logistical challenges. By systematically reviewing medications, educating patients, and engaging healthcare professionals in deprescribing practices, we can achieve the desired outcome of fewer hospital admissions related to adverse drug reactions, ultimately improving patient safety and healthcare quality.

References

• Earl, T., Katapodis, N., & Schneiderman, S. (2020). Reducing Adverse Drug Events in Older Adults. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov
• Pretorius, R., Gataric, G., Swedlund, S., & Miller, J. (2013). Reducing the Risk of Adverse Drug Events in Older Adults. American Academy of Family Physicians. https://www.aafp.org
• Barker, K. N., et al. (2014). Deprescribing in Older Adults: Impact and Strategies. Journal of Geriatric Pharmacology, 9(3), 123-134.
• Gillespie, U., et al. (2014). Medication Review to Reduce Adverse Drug Events in Elderly Patients. BMJ Quality & Safety, 23(11), 906–916.
• Maher, R. L., et al. (2014). Clinical consequences of polypharmacy in older adults. Journal of Clinical Pharmacology, 54(1), 9-13.
• Fitzgerald, R., et al. (2016). Improving Patient Outcomes Through Education and Counseling. Patient Education and Counseling, 102(2), 240-245.
• Ambrosioni, E., et al. (2014). Evidence-Based Approaches to Managing Polypharmacy and Drug Interactions. Drugs & Aging, 31(8), 607-612.
• Leipzig, R. M., et al. (2017). Strategies for Deprescribing in Older Adults. Drugs & Aging, 34(7), 491-502.